Page 1 | Search Results | Blood | American Society of Hematology

1-17 of 17

Sort by

Sort Order Select

Journal Articles

Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

Blood (2023) 142 (Supplement 1): 4898.

https://doi.org/10.1182/blood-2023-180906

Published: 2023

Journal Articles

Low-Dose ATG Has the Same Risk of CMV Reactivation after Allogeneic PBSCT As Ptcy, but Letemovir Is Effective in Preventing CMV Reactivation

Takahide Ara, Yuta Hasegawa, Hiroyuki Ohigashi, Toshihiro Matsukawa, Souichi Shiratori, Atsushi Yasumoto, Hideki Goto, Masahiro Onozawa, Masao Nakagawa, Kaoru Kahata, Tomoyuki Endo, Daigo Hashimoto, Takanori Teshima

Blood (2023) 142 (Supplement 1): 3546.

https://doi.org/10.1182/blood-2023-191306

Published: 2023

Journal Articles

Genetic Mutation and Outcome of Venetoclax-Based Therapy in Newly Diagnosed AML in the Real World: Hokkaido Leukemia Net Study

Blood (2023) 142 (Supplement 1): 1470.

https://doi.org/10.1182/blood-2023-173909

Published: 2023

Journal Articles

Subclinical Minute FLT3 -ITD Clone Can be Detected in Clinically FLT3 -ITD-Negative Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 9094–9095.

https://doi.org/10.1182/blood-2022-162325

Published: 2022

Journal Articles

Prognostic Impact of CEBPA bZIP Domain Mutation in Cytogenetically Normal Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 8950–8951.

https://doi.org/10.1182/blood-2022-158653

Published: 2022

Journal Articles

Better Prognosis of Dominant-Negative Type of IKZF1 Deletion in BCR-ABL- positive Adult B-Cell Acute Lymphoblastic Leukemia

Blood (2022) 140 (Supplement 1): 9207–9208.

https://doi.org/10.1182/blood-2022-157881

Published: 2022

Journal Articles

Clinical Features of Complex Karyotype in Newly Diagnosed Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 3210–3211.

https://doi.org/10.1182/blood-2022-157874

Published: 2022

Journal Articles

Cytomegalovirus Gastroenteritis in Patients with Acute Graft-Versus-Host Disease

Yu Akahoshi, Shun-ichi Kimura, Yuma Tada, Toshihiro Matsukawa, Masaharu Tamaki, Noriko Doki, Naoyuki Uchida, Masatsugu Tanaka, Hirohisa Nakamae, Takuro Kuriyama, Ken-ichi Matsuoka, Takashi Ikeda, Takafumi Kimura, Takahiro Fukuda, Yoshinobu Kanda, Yoshiko Atsuta, Makoto Murata, Seitaro Terakura, Hideki Nakasone

Blood (2021) 138 (Supplement 1): 3918.

https://doi.org/10.1182/blood-2021-147658

Published: 2021

Journal Articles

Mcm2 Deficiency Leads to Bone Marrow Failure and Lymphoid Malignancies Dependent on Age and Genetic Background

Toshihiro Matsukawa, Yin Mianmian, Timour Baslan, Yang Jo Chung, Dengchao Cao, Ryan Bertoli, Jack Zhu, Robert L. Walker, Amy Freeland, Erik Knudsen, Paul S. Meltzer, Peter D. Aplan

Blood (2021) 138 (Supplement 1): 2223.

https://doi.org/10.1182/blood-2021-147373

Published: 2021

Journal Articles

HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR

Blood (2020) 135 (26): 2413–2419.

https://doi.org/10.1182/blood.2020005395

Published: 2020

Includes: Supplemental data

Journal Articles

Mice with a Unique Mutator Phenotype Allow Detection of Lymphoid Leukemia Tumor Suppressor Genes

Mianmian Yin, PhD, Timour Baslan, PhD, Amy Freeland, PhD, Toshihiro Matsukawa, PhD, Steven C. Pruitt, PhD, Peter D. Aplan, MD

Blood (2018) 132 (Supplement 1): 1332.

https://doi.org/10.1182/blood-2018-99-115176

Published: 2018

Journal Articles

Severe Adverse Events By First Line Tyrosine Kinase Inhibitors Decrease Survival Rate in Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Shuichi Ota, MD PhD, Toshihiro Matsukawa, MD PhD, Satoshi Yamamoto, MD, Shinichi Ito, MD, Motohiro Shindo, MD, Kazuya Sato, MD PhD, Takeshi Kondo, MD PhD, Tohru Takahashi, MD, Tsutomu Sato, MD PhD, Yasutaka Kakinoki, MD PhD, Hajime Kobayashi, MD, Mitsutoshi Kurosawa, MD PhD

Blood (2016) 128 (22): 1898.

https://doi.org/10.1182/blood.V128.22.1898.1898

Published: 2016

Journal Articles

Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells

Blood (2014) 123 (25): 3932–3942.

https://doi.org/10.1182/blood-2013-01-476747

Published: 2014

Includes: Supplemental data

Journal Articles

Monosomal Karyotype in Myeloid Malignancies Is Prognostically Worse Even After Allogeneic Hematopoietc Stem Cell Transplantaion; Results From Two Transplant Centers,

Minauchi Koichiro, MD, Akio Shigematsu, MD, PhD, Masanobu Nakata, MD, Toshihiro Matsukawa, MD, Koh Ebata, MD, Tomohiro Yamakawa, MD, Tomoyuki Saga, MD, Kanako Shima, MD, Makoto Ibata, MD, PhD, Junichi Sugita, MD, PhD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Masahiro Ogasawara, MD, Ph.D, Yoshio Kiyama, MD, Masahiro Imamura, MD, PhD, Naoki Kobayashi, MD, Ph.D

Blood (2011) 118 (21): 4154.

https://doi.org/10.1182/blood.V118.21.4154.4154

Published: 2011

Journal Articles

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Masahiro Ogasawara, MD, Ph.D, Tomohiro Yamakawa, MD, Yuki Katsura, MD, Kanako Shima, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Koichiro Minauchi, MD, Masanobu Nakata, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, Ph.D, Teiichi Hirano, MD, Ph.D, Naoki Kobayashi, MD, Ph.D, Yoshio Kiyama, MD, Naoto Hirano, MD, Ph.D

Blood (2010) 116 (21): 2101.

https://doi.org/10.1182/blood.V116.21.2101.2101

Published: 2010

Journal Articles

Imatinib Mesylate Impairs the Function of Human Regulatory T Cells (Tregs) and Reverses the Inhibition of Immune Responses to Imatinib-Resistant CML Cells by Tregs.

Masahiro Ogasawara, Toshihiro Matsukawa, Yuki Katsura, Kanako Shima, Minoru Kanaya, Mizuha Kosugi, Satomi Matsuoka, Shiro Fujii, Shinsuke Noguchi, Shuichi Ota, MD, PhD, Masanobu Nakata, MD, Kiyotoshi Imai, Teiichi Hirano, Naoki Kobayashi, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD

Blood (2009) 114 (22): 4728.

https://doi.org/10.1182/blood.V114.22.4728.4728

Published: 2009

Journal Articles

Pre-Treatment Serum Soluble Interleukin-2 Receptor Value Significantly Predicts Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Shinsuke Noguchi, MD, Masanobu Nakata, MD, Kanako Shima, MD, Yuki Katsura, MD, Toshihiro Matsukawa, MD, Minoru Kanaya, MD, Satomi Matsuoka, MD, Mizuha Kosugi, MD, Shiro Fujii, MD, Shuichi Ota, MD, PhD, Kiyotoshi Imai, MD, PhD, Teiichi Hirano, MD, PhD, Naoki Kobayashi, MD, PhD, Masahiro Ogasawara, MD, PhD, Yoshio Kiyama, MD, Masaharu Kasai, MD, PhD

Blood (2009) 114 (22): 3948.

https://doi.org/10.1182/blood.V114.22.3948.3948

Published: 2009

NARROW

Impact of Letermovir Prophylaxis for Cytomegalovirus Reactivation on Post-Transplant Outcomes 100 Days before and after Allogeneic Hematopoietic Cell Transplantation

Low-Dose ATG Has the Same Risk of CMV Reactivation after Allogeneic PBSCT As Ptcy, but Letemovir Is Effective in Preventing CMV Reactivation

Genetic Mutation and Outcome of Venetoclax-Based Therapy in Newly Diagnosed AML in the Real World: Hokkaido Leukemia Net Study

Subclinical Minute FLT3 -ITD Clone Can be Detected in Clinically FLT3 -ITD-Negative Acute Myeloid Leukemia

Prognostic Impact of CEBPA bZIP Domain Mutation in Cytogenetically Normal Acute Myeloid Leukemia

Better Prognosis of Dominant-Negative Type of IKZF1 Deletion in BCR-ABL- positive Adult B-Cell Acute Lymphoblastic Leukemia

Clinical Features of Complex Karyotype in Newly Diagnosed Acute Myeloid Leukemia

Cytomegalovirus Gastroenteritis in Patients with Acute Graft-Versus-Host Disease

Mcm2 Deficiency Leads to Bone Marrow Failure and Lymphoid Malignancies Dependent on Age and Genetic Background

HLA loci predisposing to immune TTP in Japanese: potential role of the shared ADAMTS13 peptide bound to different HLA-DR

Mice with a Unique Mutator Phenotype Allow Detection of Lymphoid Leukemia Tumor Suppressor Genes

Severe Adverse Events By First Line Tyrosine Kinase Inhibitors Decrease Survival Rate in Patients with Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia

Hes1 promotes blast crisis in chronic myelogenous leukemia through MMP-9 upregulation in leukemic cells

Monosomal Karyotype in Myeloid Malignancies Is Prognostically Worse Even After Allogeneic Hematopoietc Stem Cell Transplantaion; Results From Two Transplant Centers,

Efficient Generation of HLA-A24-Restricted WT1-Specific Cytotoxic T Lymphocytes Using Gene-Engineered Artificial Antigen-Presenting Cells

Imatinib Mesylate Impairs the Function of Human Regulatory T Cells (Tregs) and Reverses the Inhibition of Immune Responses to Imatinib-Resistant CML Cells by Tregs.

Pre-Treatment Serum Soluble Interleukin-2 Receptor Value Significantly Predicts Survival in Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only